GLP-1s effectively combat kidney disease: A new study highlights Ozempic and Wegovy’s promise in the renal space. We address the prescription drug spending elephant in the room.
Consumers trust pharmacists to provide medical services: But barriers prevent pharmacists from having an expanded role in patient care.
Most patients quit GLP-1 weight loss drugs before seeing benefits: Here’s the reality for patients taking GLP-1s for weight loss and the unique opportunity it presents for pharma marketers.
BCW rolls out health influencer marketing service: The agency’s launch comes while consumers are highly engaged with health content on social media.
Hims & Hers offers compounded GLP-1 weight loss drugs: Will offering non-FDA-approved GLP-1s be worth the risk for Hims? We think so.
Health systems are carefully evaluating genAI documentation solutions: But the market is quickly crowding with new tools. Price and product differentiation will be paramount.
FDA’s drug advertising transparency rule takes hold: Here’s how it impacts pharma and which advertisers will see the most success reaching and converting patients.
Patients with health conditions want to learn about their medication options: We explore how pharma brands and marketers can better position themselves as patient educators.
Uber steers into the caregiver space: Uber’s newest feature could help patients and insurers alike. But there are a few factors that could prevent Uber Caregiver from reaching its full potential.
Healthcare leaders applaud Ascension’s cyberattack response: A healthcare organization’s reaction to a cyberattack can make all the difference when it comes to reputation.
GoodRx inks direct contracting agreement with Kroger: Investors should be happy with GoodRx’s redefined approach to drug pricing and pharma partnerships.
LG bets on home healthcare: But the company may struggle to capture market share from entrenched home health rivals like Best Buy Health and Samsung.
Transcarent to release healthcare AI chatbot: We unpack the utility the GPT-4-powered tool could hold for patients and give our take on why the lauded chat-based virtual care revolution is overblown.
Ogilvy launches influencer marketing offering for health brands: We explore the value that agencies can bring to healthcare and pharma brands looking to forge tie-ups with social health influencers.
Some hospitals refuse surgeries without upfront payments: We explore the broader implications this could have on health equity.
Pharma advertisers are pushing into CTV: They’re evolving with consumers’ ever-changing media consumption trends.
Kraft Heinz weighs Oscar Mayer sale amid mounting criticism of processed foods: The company is on a multi-year path to make its products more nutritious in response to shifting consumer preferences.
Patients frequently go out of network for mental healthcare vs. medical care: The No. 1 factor driving this discrepancy? Lack of coverage options. The Biden administration is calling on insurers to change that, though.
New DOJ task force investigates anticompetitive behavior in healthcare: The feds want to rein in vertical integration in healthcare. UnitedHealth Group will likely be under the spotlight first.
Positive experiences are the key to retaining patients: We dive into new study results showing why US consumers switch providers and insurers and unpack what both need to do to stop customers from jumping ship.